Navigation Links
Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
Date:12/19/2011

HOLLYWOOD, Calif., Dec. 19, 2011 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) (www.medboxinc.com) today announced their newly appointed officers and directors after their acquisition of Prescription Vending Machines, Inc. (PVM).

PVM's Founder and CEO, Vincent Mehdizadeh, commented on his fellow appointees by stating, "I am thrilled to have such dynamic individuals on our team, which are comprised of Doctorates and MBAs. We are entering a period of rapid growth and the expertise of this team will help steer the company, set important policies, and establish a solid foundation that will support our expansion from a mid-size company to an international leader in our field." Mr. Mehdizadeh went on to state, "Since PVM is a profitable company with a solid management team, we wanted to implement PVM's officers in key positions within Medbox, Inc."

Effective December 1, 2011, the new Executive Management Team for Medbox, Inc. is as follows:

Vincent Mehdizadeh, Board Member (CEO and Founder, PVM)
Dr. Bruce Bedrick, President, Director, Board Member (COO, PVM)
Leila Guieb, Treasurer, Director, Board Member (CFO, PVM)
Christine Collins, Secretary, Director
Angelique Dolan, Board Member (Director of Marketing, PVM)

For more information on Medbox, Inc. please call the Investor Relations Department at (800) 766-1452 or go online to www.medboxinc.com

Medbox is a publicly traded company, with its stock listed on the OTC Board, ticker symbol MDBX.

About Medbox: 
Medbox is a leader in the development, sales and service of automated, biometrically controlled, dispensing and storage systems for medicine. The company also features automated, biometrically controlled, mini-storage units for other valuables. Medbox has offices throughout the world, including New York, Tokyo, Toronto, with corporate headquarters in Los Ange
'/>"/>

SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Biophysical Society announces speakers for Future of Biophysics Burroughs Wellcome Fund Symposium
2. Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference
3. DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers
4. Biophysical Society Announces winners of 2012 International Relations Committee travel awards
5. Biophysical Society announces winners of 2012 CPOW travel awards
6. EpiGen announces collaboration with Nestlé
7. Minister announces UK-India collaboration on bioenergy
8. BGI announces collaborative research agreements with Oregon State University
9. NIH TRND program announces next round of drug development projects
10. DigitalPersona Announces FingerJet OEM Fingerprint Recognition Software for Biometric Device Manufacturers and Solution Providers
11. BGI announces collaboration with Johns Hopkins University on synthetic yeast project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... of Yale researchers will lead a five-year, $3 million ... events is affecting the transport of dissolved organic matter ... say could alter the chemical composition and water quality ... funding from the National Science Foundation,s MacroSystems Biology program, ... the watershed, which begins in Canada and runs through ...
(Date:4/22/2014)... fist-like club of a mantis shrimp, a team of ... with University of Southern California and Purdue University, have ... more impact resistant and tougher than the standard used ... of this tiny crustacean, the more we realize its ... day," said David Kisailus, a Kavli Fellow of the ...
(Date:4/22/2014)... The Federation of American Societies for Experimental Biology (FASEB) ... (FY) 2013 highlighting how funding from the National Institutes ... DC, and Puerto Rico. "FASEB is pleased to make ... the significance of NIH to their state," said FASEB ... nation,s leading source for biomedical research funding, investing ...
Breaking Biology News(10 mins):Connecticut River watershed study will assess impacts of extreme rain events 2Connecticut River watershed study will assess impacts of extreme rain events 3Mantis shrimp stronger than airplanes 2Mantis shrimp stronger than airplanes 3
... of children with undiagnosed learning disorders, developmental deficits, and ... challenges, which are explored in detail in a reflective ... a peer-reviewed journal published by Mary Ann Liebert, Inc. ... ahead of print at www.liebertpub.com/gtmb ...
... been extinct for 65 million years, newly published data ... is providing invaluable insights into their paleobiology. Ammonites, shelled ... inhabited the oceans for nearly 350 million years. Specimens ... that covered North America during the Cretaceous Period demonstrate ...
... are investigating a potential new treatment for lung disease that ... is studying how statins, drugs which are commonly used to ... , There is currently no effective treatment for acute ... rates for those who become critically ill and suffer lung ...
Cached Biology News:Unexplained childhood disorders 2New discoveries in North America's Great Plains bring ammonites to life 2New discoveries in North America's Great Plains bring ammonites to life 3Queen's University Belfast lung injury study could save lives in critically ill 2
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Therapies to Address the Underlying Cause of Cystic,Fibrosis; ... SOUTH PLAINFIELD, N.J., Aug. 20 New ... that the investigational oral drug,PTC124 demonstrates activity in ... with PTC124 results in statistically significant,improvements in the ...
... Oncothyreon Inc. (Nasdaq:,ONTY) (TSX: ONY) announced today that ... on August 14, 2008 indicating that Oncothyreon does ... The NASDAQ Global Market,because it does not meet ... (i) the market value of Oncothyreon,s common stock ...
... Crystal Research Associates, LLC,announced today that ... on Generex Biotechnology Corporation (Nasdaq: GNBT ... at http://www.crystalra.com ., Generex Biotechnology ... pharmaceutical company that aims to research, develop, ...
Cached Biology Technology:PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 3Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation 3